World's Best Scientists 2026 revealed!
Annaliesa S. Anderson

Annaliesa S. Anderson

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
13211
World Ranking
13092
National Ranking
5583

Annaliesa S. Anderson publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Annaliesa S. Anderson sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 231 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Annaliesa S. Anderson D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Annaliesa S. Anderson sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 58 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Annaliesa S. Anderson is affiliated with Pfizer in the United States and has an extensive publication record in the field of medicine, particularly focusing on infectious diseases. Their research contributions span multiple subfields including infectious diseases, epidemiology, public health, environmental and occupational health, microbiology, and immunology.

The scientist's work covers a variety of topics, with notable emphasis on SARS-CoV-2 and COVID-19 research, pneumonia and respiratory infections, respiratory viral infections research, COVID-19 clinical research studies, bacterial infections and vaccines, influenza virus research studies, and viral gastroenteritis research and epidemiology.

Some of the recent significant papers authored or co-authored by Annaliesa S. Anderson include:

  • An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19 (2021), published in Science
  • Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants (2023), published in New England Journal of Medicine
  • Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults (2023), published in New England Journal of Medicine
  • Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 (2021), published in Nature Communications
  • Neutralization of BA.4-BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine (2023), published in New England Journal of Medicine

Annalesia's frequent co-authors include Kena A. Swanson, Alejandra Gurtman, William C. Gruber, David Cooper, and Nicholas Kitchin, indicating collaboration within a network of researchers focused on vaccine development and infectious disease treatment.

Their publications are commonly found in several venues, highlighting recurring contributions to journals such as Open Forum Infectious Diseases, bioRxiv (Cold Spring Harbor Laboratory), Vaccine, New England Journal of Medicine, and Vaccines. These venues reflect a focus on both clinical and translational research relevant to infectious diseases and immunology.

Best Publications

  • An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.

    Dafydd R. Owen;Charlotte M. N. Allerton;Annaliesa S. Anderson;Lisa Aschenbrenner

  • A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model

    Nelly A. Kuklin;Desmond J. Clark;Susan Secore;James Cook

  • The role of vaccines in preventing bacterial antimicrobial resistance

    Kathrin U Jansen;Charles Knirsch;Annaliesa S Anderson

  • Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19.

    Britton Boras;Rhys M Jones;Brandon J Anson;Dan Arenson

  • Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease.

    Han-Qing Jiang;Susan K. Hoiseth;Shannon L. Harris;Lisa K. McNeil

  • Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup B Neisseria meningitidis

    Ellen Murphy;Lubomira Andrew;Kwok Leung Lee;Deborah A. Dilts

  • Vaccine review: "Staphyloccocus aureus vaccines: Problems and prospects"

    Kathrin U. Jansen;Douglas Q. Girgenti;Ingrid L. Scully;Annaliesa S. Anderson

  • Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention.

    Gustavo H Dayan;Naglaa Mohamed;Ingrid L Scully;David Cooper

  • Role of Factor H Binding Protein in Neisseria meningitidis Virulence and Its Potential as a Vaccine Candidate To Broadly Protect against Meningococcal Disease

    Lisa K. McNeil;Robert J. Zagursky;Shuo L. Lin;Ellen Murphy

  • Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus

    Jasdeep S. Nanra;Sandra M. Buitrago;Shomari Crawford;Jennifer Ng

  • Staphylococcus aureus Manganese Transport Protein C Is a Highly Conserved Cell Surface Protein That Elicits Protective Immunity Against S. aureus and Staphylococcus epidermidis

    Annaliesa S. Anderson;Ingrid L. Scully;Yekaterina Timofeyeva;Ellen Murphy

  • Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors

    Annaliesa S. Anderson;Alita A. Miller;Robert G.K. Donald;Ingrid L. Scully

  • The role of vaccines in fighting antimicrobial resistance (AMR).

    Kathrin U. Jansen;Annaliesa S. Anderson

  • Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States

    Xin Wang;Amanda Cohn;Maurizio Comanducci;Lubomira Andrew

  • Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide.

    Lisa K McNeil;Ellen Murphy;Xiao-Juan Zhao;Stephen Guttmann

  • A comparative analysis of SARS-CoV-2 antivirals characterizes 3CL pro inhibitor PF-00835231 as a potential new treatment for COVID-19.

    Maren de Vries;Adil S. Mohamed;Rachel A. Prescott;Ana M. Valero-Jimenez

  • The Discovery and Development of a Novel Vaccine to Protect against Neisseria meningitidis Serogroup B Disease

    Gary W Zlotnick;Thomas R Jones;Paul Liberator;Li Hao

  • Escherichia coli and Staphylococcus aureus: leading bacterial pathogens of healthcare associated infections and bacteremia in older-age populations

    Jan T Poolman;Annaliesa S Anderson

  • A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults.

    Helen S. Marshall;Peter C. Richmond;Michael D. Nissen;Ann Wouters

  • A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.

    Robert G. K. Donald;Mike Flint;Narender Kalyan;Erik Johnson

Frequent Co-Authors

Kathrin U. Jansen
Kathrin U. Jansen Pfizer (United States)
Robert G. K. Donald
Robert G. K. Donald Pfizer (United States)
William C. Gruber
William C. Gruber Pfizer (United States)
David A. Cooper
David A. Cooper University of New South Wales
Sharon J. Peacock
Sharon J. Peacock University of Cambridge
Peter Richmond
Peter Richmond University of Western Australia
Leonard W. Mayer
Leonard W. Mayer Centers for Disease Control and Prevention
Michael D. Nissen
Michael D. Nissen University of Queensland
Robert W. Frenck
Robert W. Frenck Cincinnati Children's Hospital Medical Center
Julian Parkhill
Julian Parkhill University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens doors to a wide range of rewarding online degrees and career tracks in allied health and science fields. Many students choose practical, accessible pathways to quickly enter the healthcare workforce, with flexible options for further advancement.

For example, students interested in medical imaging can consider 1 year radiology tech programs online, providing a fast, affordable route to become a radiologic technologist. Those passionate about nutrition and wellness may be drawn to the top dietetics masters programs, where advanced study prepares graduates for roles as registered dietitians.

Entry-level healthcare careers often start with shorter programs, such as online medical assistant programs that accept financial aid, making this a practical first step for those seeking immediate employment and support. For progression, many pursue ma to lpn bridge programs online to expand their scope of practice as Licensed Practical Nurses.

Exploring these related online degrees empowers students to align their passion for biology and biochemistry with in-demand healthcare roles and flexible learning paths.

Best Scientists Citing Annaliesa S. Anderson

Trending Scientists

Recently Published Articles